JointMedica Polymotion IDE Study Reaches 95% Enrolment Following Strong Start to 2026

The Polymotion® Hip Resurfacing (PHR®) IDE study has now reached 95% enrolment, marking an important milestone as the study moves confidently toward full recruitment. The past couple of months have represented a strong and productive start to 2026, with continued momentum across participating clinical sites.

This achievement reflects sustained engagement from both surgeons and patients who are seeking modern, bone-conserving alternatives to total hip replacement.

The Polymotion® Hip Resurfacing System is an investigational device designed for active patients seeking bone-conserving alternatives to traditional hip replacement. Unlike contemporary metal-on-metal technologies, the Polymotion® system combines a Vitamin E-infused polyethylene cup with a titanium-coated shell and a metal femoral cap, avoiding metal-on-metal articulation while maintaining excellent range of motion and implant stability.

We are grateful to our investigators, study coordinators, and clinical partners for their continued dedication. Their efforts have been instrumental in advancing enrolment and supporting patient access to alternative resurfacing options, particularly for younger, active patients, including women and smaller-framed individuals.

With enrolment now nearing completion, the team remains focused on final recruitment, ongoing patient follow-up, and advancing the study through its next regulatory stages in 2026.

For More Information

To learn more about the Polymotion® Hip Resurfacing System and the IDE study, please contact: cs@jointmedica.com